Changes to the website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: , which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4914

Next 25



	Website Changes

	01/21/2020		Multimodal Surgical Treatment of High-Grade Gliomas in the Motor Area: The Impact of the Combination of Navigated Transcranial Magnetic Stimulation and Fluorescein-Guided Resection.

	01/21/2020		Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1


	01/21/2020		Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling

	01/21/2020		Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma


	01/15/2020		Musella Foundation Brain Tumor Copay program is now open!

	01/15/2020		Scientists breach brain barriers to attack tumors


	01/13/2020		Medicenna Vaults on Brain Cancer Study

	01/10/2020		Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis


	01/10/2020		Surgery may add months or years of survival for adults with rare and deadly brain cancers

	01/09/2020		Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide.


	01/08/2020		New book takes a humorous look at brain cancer

	01/08/2020		Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.


	01/07/2020		DIPG Advocacy Group Announces Congressional Briefing for Pediatric Brain Cancer

	01/06/2020		Musella Foundation Awards $250,000 Brain Tumor Research Grant


	01/05/2020		Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research

	01/04/2020		Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.


	01/04/2020		Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences?

	01/04/2020		Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma.


	12/28/2019		Made website more accessable! Click the logo on top right of any page to see!

	12/25/2019		Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma.


	12/25/2019		A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

	12/25/2019		Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study


	12/16/2019		Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.

	12/03/2019		Musella Foundation`s Annual Giving Campaign


	12/03/2019		SNO 2019: The Oncolytic Herpes Virus G47? May Lead to a Potential Cure of Malignant Glioma